Treatment of visceral leishmaniasis with sodium stibogluconate in Sudan: management of those who do not respond

REFERENCES

• Anabwani, G. M., Ngira, J. A., Dimiti, G. & Bryceson, A. D. M. (1983). Comparison of two dosage schedules of sodium stibogluconate in the treatment of visceral leishmaniasis in Kenya. Lancet, i, 210–213.
   Google Scholar
• Campbell, D. & Chadee, K. (1997). Survival strategies of Entamoeba histolytica: modulation of cell-mediated immune responses. Parasitology Today, 13, 184–190.
   PubMedGoogle Scholar
• Chulay, J. D., Bhatt, S. M., Muigai, R., Ho, M., Were, J. B. O., Chunge, C. & Bryceson, A. D. M. (1983). A comparison of three dosage regimens of sodium stibogluconate in the treatment of visceral leishmaniasis in Kenya. Journal of Infectious Diseases, 148, 148–155.
   PubMed Web of Science ®Google Scholar
• Chunge, C. N., Gachihi, G., Muigai, R., Wasunna, K., Rashid, J. R., Chuilay, J. D., Anabwani, G., Oster, C. N. & Bryceson, A. D. M. (1985). Visceral leishmaniasis unresponsive to antimonial drugs. III. Successful treatment using a combination of sodium stibogluconate plus allopurinol. Transactions of the Royal Society of Tropical Medicine and Hygiene, 79, 715–718.
   PubMed Web of Science ®Google Scholar
• Davidson, R. N., di Martino, L., Gradoni, L., Giacchino, R., Russo, R., Gaeta, G. B., Pempinello, R., Scott, S., Raimondi, F., Cascio, A., Prestileo, T., Caldeira, L., Wilkinson, R. J. & Bryceson, A. D. M. (1994). Liposomal amphotericin B (AmBisome) in Mediterranean visceral leishmaniasis: a multi-centre trial. Quarterly Journal of Medicine, 87, 75–81.
   PubMedGoogle Scholar
• Di Martino, L., Mantovani, M. P., Gradoni, L., Gramiccia, M. & Guandalini, S. (1990). Low dosage meglumine antimoniate plus allopurinol as first choice treatment of infantile visceral leishmaniasis in Italy. Transactions of the Royal Society of Tropical Medicine and Hygiene, 84, 534–535.
   PubMed Web of Science ®Google Scholar
• El Harith, A. E., Kolk, A. H. & Kager, P. (1986). A simple economical direct agglutination test for serodiagnosis and sero-epidemiological studies of visceral leishmaniasis. Transactions of the Royal Society of Tropical Medicine and Hygiene, 80, 583–587.
   PubMed Web of Science ®Google Scholar
• Heath, S., Chance, M. L. & New, R. R. C. (1984). Quantitative and ultrastructural studies on the uptake of drug loaded liposomes by mononuclear phagocytes infected with Leishmania donovani. Molecular Biochemistry and Parasitology, 12, 49–60.
   PubMed Web of Science ®Google Scholar
• Herwaldt, B. L. & Berman, J. D. (1992). Recommendations for treating visceral leishmaniasis with sodium stibogluconate (Pentostam) and review of pertinent clinical studies. American Journal of Tropical Medicine and Hygiene, 46, 296–306.
   PubMed Web of Science ®Google Scholar
• Ibrahim, M. E., Hag Ali, M., El Hassan, A. M., Theander, T. G. & Kharazmi, A. (1994). Leishmania resistance to sodium stibogluconate: drug-associated macrophage-dependent killing. Parasitology Research, 80, 569–574.
   PubMed Web of Science ®Google Scholar
• Jha, T. K. (1983). Evaluation of allopurinol in the treatment of kala-azar occurring in North Bihar, India. Transactions of the Royal Society of Tropical Medicine and Hygiene, 77, 204–207.
   PubMed Web of Science ®Google Scholar
• Jha, S. N., Singh, N. K. & Jha, T. K. (1991). Changing response to diamidine compounds in cases of kala-azar unresponsive to antimonials. Journal of the Association of Physicians of India, 39, 314–316.
   PubMedGoogle Scholar
• Kager, P. A., Rees, P. H., Wellde, B. T., Hockmeyer, W. T. & Lyerly, W. H. (1981). Allopurinol in the treatment of visceral leishmaniasis. Transactions of the Royal Society of Tropical Medicine and Hygiene, 75, 556–559. Kirk, R. & Satti, M. H. (1947). Observations on the use of sodium stibogluconate in the treatment of kala-azar. Annals of Tropical Medicine and Parasitology, 41, 14–21.
   PubMed Web of Science ®Google Scholar
• Khalil, E. A. G., Nur, N. M., Zijlstra, E. E., El Hassan, A. M. & Davidson, R. N. (1996). Failure of a combination of two antifungal drugs, terbinafine plus itraconazole, in Sudanese post kala-azar dermal leishmaniasis. Transactions of the Royal Society of Tropical Medicine and Hygiene, 90, 187–188.
   PubMed Web of Science ®Google Scholar
• Mishra, M., Biswas, U. K., Jha, D. N. & Khan, A. B. (1992). Amphotericin versus pentamidine in antimony unresponsive kala-azar. Lancet, ii, 1256–1257.
   Web of Science ®Google Scholar
• Nabors, G. S. (1997). Modulating ongoing Th2-cell responses in experimental leishmaniasis. Parasitology Today, 13, 76–79.
   PubMedGoogle Scholar
• Neal, R. A. (1987). Experimental chemotherapy. In The Leishmaniases in Biology and Medicine, Vol. 2, eds Peters, W. & Killick-Kendrick, R. pp. 793–845. London: Academic Press.
   Google Scholar
• Olliaro, P. L. & Bryceson, A. D. M. (1993). Practical progress and new drugs for changing patterns of leishmaniasis. Parasitology Today, 9, 323–328.
   PubMedGoogle Scholar
• Russo, R., Nigro, L. C., Minniti, S., Montineri, A., Gradoni, L., Caldeira, L. & Davidson, R. N. (1996). Visceral leishmaniasis in HIV infected patients: treatment with high dose liposomal amphotericin B (AmBisome). Journal of Infection, 32, 133–137.
   PubMed Web of Science ®Google Scholar
• Siddig, M. A., Ghalib, H. W., Shillington, D. C. & Peterson, E. A. (1988). Visceral leishmaniasis in the Sudan: comparative parasitological methods of diagnosis. Transactions of the Royal Society of Tropical Medicine and Hygiene, 82, 66–68.
   PubMed Web of Science ®Google Scholar
• Sokal, J. A. (1975). Measurement of delayed skin test responses. New England Journal of Medicine, 293, 501–502.
   PubMed Web of Science ®Google Scholar
• Sundar, S., Kumar, K. & Singh, V. P. (1990). Ketoconazole in visceral leishmaniasis. Lancet, ii, 1582–1583.
   Web of Science ®Google Scholar
• Thakur, C. P., Kumar, M., Kumar, P., Mishra, B. N. & Pandey, A. K. (1988). Rationalization of regimens of treatment of kala-azar with sodium stibogluconate in India: a randomized study. British Medical Journal, ii, 1557–1561.
   Web of Science ®Google Scholar
• Thakur, C. P., Kumar, M. & Pandey, A. K. (1991). A comparison of regimens of treatment of antimony-resistant kala-azar patients: a randomized study. American Journal of Tropical Medicine and Hygiene, 45, 435–441.
   PubMed Web of Science ®Google Scholar
• World Health Organization (1990). Control of Leishmaniasis. Technical Report Series No. 793. Geneva: WHO.
   Google Scholar
• Zijlstra, E. E, Siddig, M. A., El Hassan, A. M., El Toum, I. A., Ghalib, H. W., Sondrop, E. & Winkler, A. (1991). Kala-azar in displaced people from southern Sudan: epidemiological, clinical and therapeutic findings. Transactions of the Royal Society Tropical Medicine and Hygiene, 85, 365–369.
   PubMed Web of Science ®Google Scholar
• Zijlstra, E. E., Siddig, M. A., El Hassan, A. M., El Toum, I. A., Ghalib, H. W. & Kager, P. A. (1992a). Kala-azar: a comparative study of parasitological methods and the direct agglutination test in diagnosis. Transactions of the Royal Society of Tropical Medicine and Hygiene, 86, 505–507.
   PubMed Web of Science ®Google Scholar
• Zijlstra, E. E., Siddig, M. A., El Hassan, A. M., El Toum, I. A., Satti, M. & Ghalib, H. W. (1992b). Clinical aspects of kala-azar in children from the Sudan: a comparison with the diseases in adults. Journal of Tropical Pediatrics, 38, 17–21.
   PubMed Web of Science ®Google Scholar
• Zijlstra, E. E., Siddig, M. A., El Hassan, A. M., Hofland, C., El Toum, I. A., Satti, M. & Ghalib, H. W. (1993). The treatment of kala-azar in the Sudan with sodium stibogluconate: a randomized trial of three dosage regimens. Transactions of the Royal Society of Tropical Medicine and Hygiene, 87, 307–309.
   PubMed Web of Science ®Google Scholar